Danggui Niantong decoction ameliorates joint inflammation and cardiopulmonary injury in TNF-Tg mice

Abstract

Objective: Rheumatoid arthritis (RA) is a common autoimmune disease characterized by multiple joint lesions and systemic complications. Danggui Niantong decoction (DGNTT) has been clinically used for RA treatment; however, its beneficial effect on cardiopulmonary complications has not been reported.

Methods: Female tumor necrosis factor-transgenic (TNF-Tg) mice were used to evaluate the therapeutic effects of DGNTT on arthritis and cardiopulmonary complications. Methotrexate (MTX) served as a positive control. Histopathological assessment of the joint sections was performed using hematoxylin and eosin (HE), Alcian Blue/Orange G, and tartrate-resistant acid phosphatase staining. Bone mass was assessed by micro-computed tomography, inflammatory infiltrates in the heart and lungs were evaluated by HE staining, cardiopulmonary fibrotic injury was identified by Masson's trichrome staining, and hypertrophy of mouse cardiomyocytes was measured by wheat germ agglutinin (WGA) staining.

Results: DGNTT mitigated the inflammation of the ankle joint synovium, decreased the number of osteoclasts, and increased the area of cartilage and bone mass in TNF-Tg mice. In addition, DGNTT decreased the infiltration of inflammatory cells into the lung and heart tissues, accompanied by a reduction in cardiopulmonary fibrosis and myocardial cell hypertrophy in TNF-Tg mice. As a positive control drug, MTX attenuated the pathological changes in joints, but had no beneficial effect on cardiopulmonary inflammation and fibrosis in TNF-Tg mice.

Conclusions: DGNTT improved joint lesions and alleviated cardiopulmonary complications in TNF-Tg mice.

Keywords

Cardiovascular system disease / Danggui Niantong decoction / Interstitial lung disease / Rheumatoid arthritis / TNF-Tg mice

References

[[1]] Sparks JA.Rheumatoid arthritis. Ann Intern Med. 2019;170(1):ITC1-ITC16.

[[2]] McInnes I, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-2219.

[[3]] Pinheiro F, Souza D, Sato E.A study of multiple causes of death in rheumatoid arthritis. J Rheumatol. 2015;42(12):2221-2228.

[[4]] Young A, Koduri G, Batley M, et al.Early Rheumatoid Arthritis Study (ERAS) Group. Mortality in rheumatoid arthritis Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford). 2007;46(2):350-357.

[[5]] Laria A, Lurati A, Zizzo G, et al.Interstitial lung disease in rheumatoid arthritis: a practical review. Front Med. 2022;9:837133.

[[6]] Chen Z, Bozec A, Ramming A, et al.Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol. 2019;15(1):9-17.

[[7]] Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023-2038.

[[8]] Xiong L, Xiong L, Ye H, et al.Animal models of rheumatoid arthritis-associated interstitial lung disease. Immun Inflamm Dis. 2021;9(1):37-47.

[[9]] Hakala M.Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest. 1988;93(1):114-118.

[[10]] Olson A, Swigris J, Sprunger D, et al.Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183(3):372-378.

[[11]] Avina-Zubieta JA, Thomas J, Sadatsafavi M, et al.Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71(9):1524-1529.

[[12]] Aviña-Zubieta JA, Choi HK, Sadatsafavi M, et al.Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59(12):1690-1697.

[[13]] Ghosh R, Alajbegovic A, Gomes AV.NSAIDs and cardiovascular diseases: role of reactive oxygen species. Oxid Med Cell Longev. 2015;2015:536962.

[[14]] Avina-Zubieta JA, Abrahamowicz M, De Vera MA, et al.Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology. 2012;52(1):68-75.

[[15]] Conway R, Low C, Coughlan RJ, et al.Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheumatol. 2014;66(4):803-812.

[[16]] Nakashita T, Ando K, Kaneko N, et al.Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis. BMJ Open. 2014;4(8):e005615.

[[17]] Kelly C, Matteson E, Aringer M, et al.Opo124 effects of nintedanib in patients with progressive fibrosing interstitial lung disease associated with rheumatoid arthritis (RA-ILD) in the Inbuild trial. Ann Rheum Dis. 2021;80(Suppl 1):6962-6969.

[[18]] Lin TT, Wu CK, Liao MT, et al.Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-a nationwide cohort study. PLoS One. 2017;12(12):e0188720.

[[19]] Hu R.Meta analysis of Danggui Niantong decoction in treating rheumatoid arthritis of damp heat bi obstruction type. Gansu Med J. 2021;40(2):133-138.

[[20]] Zheng H.Clinical observation on 30 cases of rheumatoid arthritis treated with Danggui Niantong decoction. J Sichuan Tradit Chin Med. 2015;33(3):102-103.

[[21]] Yuan L.Clinical observation on 53 cases of rheumatoid arthritis treated with Danggui Niantong decoction J Shandong Univ Tradit Chin Med.2008;5):407-408.

[[22]] Ge L, Shi ZM.Comparison of clinical effects of different dosage forms of Danggui Niantong decoction on rheumatoid arthritis. Shandong J Tradit Chin Med. 2017;36(1):17-19.

[[23]] Yuan L. Regulation of Danggui Niantong Tang Jiawei plaster on adjuvant induced apoptosis of synovial cells. TCM Emerg. 2011;20(11):1780-1781+1783.

[[24]] Yuan LX, Li QY, Yi GZ, et al.Proteomic study on Danggui Niantong decoction in preventing and treating synovial lesions in rheumatoid arthritis rats. Tradit Chin Drug Res Clin Pharmacol. 2013;24(6):565-569.

[[25]] Bell RD, Wu EK, Rudmann CA, et al.Selective sexual dimorphisms in musculoskeletal and cardiopulmonary pathologic manifestations and mortality incidence in the tumor necrosis factor-transgenic mouse model of rheumatoid arthritis. Arthritis Rheumatol. 2019;71(9):1512-1523.

[[26]] Wang T, Jia Q, Chen T, et al.Corrigendum: alleviation of synovial inflammation of Juanbi-Tang on collagen-induced arthritis and TNF-Tg mice model. Front Pharmacol. 2020;11:1127.

[[27]] Kenney HM, Wu CL, Loiselle AE, et al.Single-cell transcriptomics of popliteal lymphatic vessels and peripheral veins reveals altered lymphatic muscle and immune cell populations in the TNF-Tg arthritis model. Arthritis Res Ther. 2022;24(1):64.

[[28]] Sun W, Zhang H, Wang H, et al.Targeting notch-activated M1 macrophages attenuates joint tissue damage in a mouse model of inflammatory arthritis. J Bone Miner Res. 2017;32(7):1469-1480.

[[29]] Wang Y, Chen T, Yang C, et al.Huangqi Guizhi Wuwu decoction improves arthritis and pathological damage of heart and lung in TNF-Tg mice. Front Pharmacol. 2022;13:871481.

[[30]] Kenney HM, Wood RW, Ramirez G, et al.Implementation of automated behavior metrics to evaluate voluntary wheel running effects on inflammatory-erosive arthritis and interstitial lung disease in TNF-Tg mice. Arthritis Res Ther. 2023;25(1):17.

[[31]] Wu EK, Henkes ZI, McGowan B, et al. TNF-induced interstitial lung disease in a murine arthritis model: accumulation of activated monocytes, conventional dendritic cells, and CD21+/CD23- B cell follicles is prevented with anti-TNF therapy. J Immunol. 2019;203(11):2837-2849.

[[32]] Li P, Schwarz E.The TNF-alpha transgenic mouse model of inflammatory arthritis. Springer Semin Immunopathol. 2003;25(1):19-33.

[[33]] Ashcroft T, Simpson JM, Timbrell V.Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41(4):467-470.

[[34]] Favalli EG, Biggioggero M, Crotti C, et al.Sex and management of rheumatoid arthritis. Clin Rev Allergy Immunol. 2019;56(3):333-345.

[[35]] Saag KG, Teng GG, Patkar NM, et al.American College of Rheumatology. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59(6):762-784.

[[36]] Grant JRW, Cannon W, Clegg D, et al.Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis. Arthritis Rheumatis. 1983;26(10):1269-1274.

[[37]] Carlos WCM, Bedrossian WM.Methotrexate induced diffuse interstitial pulmonary fibrosis. Methotreate Pulmonary Fibros. 1979;72(3):313-318.

[[38]] van der Veen M, Dekker J, Dinant H, et al. Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis. J Rheumatol. 1995;22(9):1766-1768.

[[39]] Chollet-Martin CS, Montravers P.High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infec Immun. 1993;61(11):4553-4559.

[[40]] Hans MAM, Folkesson G, Caroline A, et al.Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. Am Soc Clin Investig. 1995;96(1):107-116.

[[41]] Yamauchi Y, Okazaki H, Desaki M, et al.Methotrexate induces interleukin-8 production by human bronchial and alveolar epithelial cells. Clin Sci. 2004;106(6):619-625.

[[42]] Fujimori Y, Kataoka M, Tada S, et al.The role of interleukin-8 in interstitial pneumonia. Respirol. 2003;8(1):33-40.

[[43]] Juge PA, Lee JS, Lau J, et al.Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur Respir J. 2021;57(2):2000337.

[[44]] Kiely P, Busby A, Nikiphorou E, et al.Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts. BMJ Open. 2019;9(5):e028466.

[[45]] Ibfelt E, Jacobsen R, Kopp T, et al.Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study. Rheumatol. 2021;60(1):346-352.

[[46]] Blunder M, Liu X, Kunert O, et al.Polyacetylenes from Radix et Rhizoma Notopterygii incisi with an inhibitory effect on nitric oxide production in vitro. Planta Med. 2014;80(5):415-418.

[[47]] Lu C, Li Y, Hu S, et al.Scoparone prevents IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through the PI3K/Akt/NF-κB pathway. Biomed Pharmacother. 2018;106:1169-1174.

[[48]] Kim HL, Woo SM, Choi WR, et al.Scopoletin downregulates MMP-1 expression in human fibroblasts via inhibition of p38 phosphorylation. Int J Mol Med. 2018;42(4):2285-2293.

[[49]] Li Y.Study on anti inflammatory activity of volatile oil from atractylodes atractylodes. J Liaoning Univ TCM. 2013;15(2):71-72.

[[50]] Li L.Effects of notopterygium notopterygium extract on Thl/Th2 cell balance and p38 signal pathway in asthmatic mice. Acta Anatomica Sinica. 2013;44(6):819-823.

[[51]] Chen G, Pan SQ, Shen C, et al.Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-kappaB pathways. Acta Pharmacol Sin. 2014;35(4):463-475.

RIGHTS & PERMISSIONS

2023 Acupuncture and Herbal Medicine